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. Glucose production in ACE cells with different gluconeogenic substrates was measured as described in Methods. Mean ± SEM; n = 2. Figure S2 . Lactate production was measured in ACE and WT cells over a range of palmitate concentrations. ACE cells consume less glucose than WT and produce less lactate. *p < 0.05 compared to corresponding WT control. Mean ± SEM; n = 3-6. Figure S3 . Malic Enzyme 1 (ME1) levels over time after knockdown of ME1 using siRNA as described in Methods. Fatty acid uptake assay was started at time zero and continued for 24 hours. ME1 was knocked down nearly 90% for the duration of the experiment. Mean ± SEM; n = 3. . Experimental Protocol-1 for mouse experiments. Mice were weaned at 3 weeks and fed a standard chow diet until 6 weeks of age. At six weeks of age, mice were injected with either ACEAB or LACZ and placed on a standard chow or high fat diet. For 6 weeks mice were housed in cages of 1-4 and body weight was measured weekly. At 10/11 weeks of age mice (12/13 weeks for males) were fasted overnight and blood was collected via retro-orbital bleed. Six weeks post injection mice analyzed with NMR and sacrificed. Figure S5 . Alanine aminotransferase (ALT) serum levels were measured four weeks after tail vein injection of plasmid DNA. Mean ± SEM; n = 4-5. Figure S6 . Percentage weight gain relative to F-lacZ mice for F-ACE and F-lacZ mice on HFD for 6 weeks. F-ACE mice gain less weight on HFD compared to F-lacZ. This figure includes weight gain data for 5 independent ACE and lacZ injection sets. Typically 3-6 mice were injected with lacZ or ACE per injection set. This normalization allows comparison of weight gain between different injection sets where litter size (Koopman et al., 1990; Roberts et al., 1988) was found to influence total weight gain. Mean ± SEM Figure S7 . Isocitrate lyase (ACEA) and malate synthase (ACEB) gene expression levels between male and female ACE mice as determined by RT-PCR. Female mice expressing the glyoxylate shunt resist diet-induced obesity to a greater extent than male mice and this difference is not due to differences in transgene gene expression. Mean ± SEM, n=3-4. Figure S8 . Experimental Protocol-2 for mouse experiments. Female mice were weaned at 3 weeks and fed a low fat chow diet until 6 weeks of age. At six weeks of age, mice were injected with either ACEAB or LACZ and placed on a high fat diet. Two weeks after injection mice were analyzed in metabolic cages. Six weeks post injection fat pads were analyzed, blood was collected after overnight fast, and mice were sacrificed. Figure S9 . Fasting plasma insulin levels were measured in female ACE and lacZ injected mice after 6 weeks on HFD. F-ACE and F-lacZ were found to have similar plasma insulin concentrations. Mean ± SEM; n = 3. Tables   Table S1: Metabolite abbreviations used for representation of glucose, fatty acid, and triglyceride metabolism and oxidative phosphorylation ( Figure 3B ). 
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This analysis can also be carried out using convex analysis (Liao et al., 1996) or extreme pathway analysis (Schilling et al., 2000) . (Chell et al., 1978) and malate synthase (Sundaram et al., 1980) (Bradford, 1976) . Metabolites were quantified using high performance liquid chromatography (HPLC) on an Agilent 1100 model (Agilent Technologies, Palo Alto, CA) consisting of a binary pump, autosampler, and degasser connected to an organic acid Aminex HPX-87H column (300x7.8mm, Bio-Rad). A mobile phase of 5mM sulfuric acid was used and the column was maintained at 65 o C with a flowrate of 0.6mL/min.
Lactate and other organic acids were quantified with a diode array detector (Agilent Technologies) at wavelengths of 210nm and 254nm. Glucose and other non-UV absorbing compounds were quantified using a refractive index detector (Agilent Technologies). Standard curves were prepared before each set of samples was analyzed.
Concentration profiles were normalized to the total amount of protein or cell number.
Gluconeogensis Assay. Gluconeogensis was assed as previously described (Zhou et al., 2005) [U-13 C] glycerol, or no gluconeogenic substrate. Glucose concentration in the medium was then quantified using HPLC and 13 C enrichment was determined by converting glucose to pentacetate derivative (Tserng and Kalhan, 1983) and GC-MS analysis (Sriram et al., 2008) . Glucose carbons 2-6, m/z 98 in the mass spectrum (Tserng and Kalhan, 1983 ) after electron ionization, were analyzed in the selected ion monitoring mode.
Fatty Acid Fluorescence Uptake Assay. Fatty acid fluorescence uptake assays were performed using QBT FA Uptake Assay according to manufacturer's protocols with minor modifications (Molecular Devices, Sunnyvale, CA) and imaged as previously described (Fung et al., 2005) . Assays were performed using 8-well chambered coverglass culture dishes (Lab-Tek, Rochester, NY) with flat glass bottoms.
ACE and WT cells were seeded 90% confluent (1.27*10 5 cells/well) the night before assay was to be performed. All loading buffers were prepared exactly as recommended by manufacturer. On the day of the assay, medium was aspirated and cells were incubated in 333uL serum free DMEM medium for 1 hour. After serum starving, 333uL
loading buffer was added to each well and fluorescence was monitored.
14 CO 2 Production from [U-14 C] Palmitate. Production of 14 CO 2 was measured as previously described (Harwood et al., 2003) After incubation, the complexes were added drop-wise to the cells. After 48 hours, either metabolic analysis (DMEM + 300uM palmitate) was performed or total RNA was harvested for quantification to verify knockdown. Quantitative RT-PCR was performed using SYBR Green chemistry and Smart Cycler (Cephied, Sunnyvale, CA) and fold changes were calculated using ΔΔC t method with beta-actin as an endogenous control.
Primer sets were Quantitect Primer assays (Qiagen, Valencia, CA). Transfection of a non-silencing fluorescent siRNA had no effect on phenotype.
Real-Time PCR. For real-time pcr (RT-PCR) analysis, total RNA was isolated using
RNeasy-plus columns (Qiagen, Valencia, CA). First strand cDNA was synthesized using either 2-3ug (HepG2) or 500ng (mouse) of RNA and Superscript III Reverse Transcriptase (Invitrogen, Carlsbad, CA). Quantitative RT-PCR was performed using SYBR Green chemistry, Quantitect Primer Assays (Qiagen, Valencia, CA), and Smart
Cycler (Cephied, Sunnyvale, CA) and fold changes were calculated using ΔΔC t method (Livak and Schmittgen, 2001 )with beta-actin as an endogenous control. Expression changes were verified using RT-PCR. Our data was submitted to the NCBI Gene Expression Omnibus in MIAME format with access number GSE5903. The data can be accessed at:
Microarray Expression
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=tzqrpeciomgaqzy&acc=GSE5903
Western Blotting. To determine the expression of MLS-ACEA and MLS-ACEB, proteins were extracted and concentration was determined as previously described (Bradford, 1976) . Twenty micrograms of protein were separated on a 7.5% Tris-HCl SDS-PAGE gel and electroblotted onto polyvinylidene diflouride membranes (Bio-Rad, Hercules, CA) overnight at 4 o C using standard methods. The membranes were blocked in 0.01M PBS, 0.05% Tween 20 buffer (PBST) containing 5% blotto for 1 hour at room temperature. To detect MLS-aceA, the membranes were incubated with anti-V5-HRP
(1:1000) (Invitrogen, Carlsbad, CA) for 2.5 hours. For MLS-aceB detection, the membrane was incubated with anti-myc-HRP (1:5000) (Invitrogen, Carlsbad, CA) for 2 hours. The membranes were washed for 30min in PBST and developed using an ELC- Tail Vein Injections. Six to seven week old male and female mice (18-24g) were tail vein injected (Alino et al., 2003; Bates et al., 2006; Huang et al., 2006) The entire solution was immediately injected with a 27-gauge needle into the tail vein within 7 seconds. For pLIVE-lacZ injections, the same procedure was followed with the following exceptions: 10uL of the plasmid was mixed with 180uL sterile endotoxin free water and 10uL TransIT In Vivo Polymer solution.
Experimental Protocol-1. Immediately after injection, male and female mice were placed on either a chow diet or high fat diet. For 6 weeks, body weight was measured weekly. At the end of four weeks, blood from females was collected via retro-orbital bleed after an overnight fast and stored at -80°C until further analysis (Castellani et al., 2008 ) (blood from males was collected in similar fashion after 6 weeks). Six weeks postinjection fat and lean mass was determined with a mouse Minispec (Brucker Woodlands, TX) and data was analyzed with software from Echo Medical Systems (Houston, TX) as Liver ATP. Liver total ATP was measured as described (Evans et al., 2008 ) with modifications using a bioluminescence based Eliten ATP Assay System (Promega, NaCl, 1mM EDTA, 0.5% Triton X-100). After homogenization, 173uL of homogenate was mixed with 28uL of 20% Triton X-100 and the sample was vortexted for 2-4sec and centrifuged at 6000rpm for 1min at RT. The supernatant was transferred to a new tube after homogenization of the lipid partition and the TG content was measured using a triglyceride determination kit. Samples were normalized according to protein amount.
Indirect Calorimetry, Feeding and Activity. Animals were housed individually in a series of eight, airtight chambers designed to assess the metabolic activity of mice over three 12 hr light / 12 hr dark cycles (Oxymax, Columbus Instruments, OH). A standard gas mixture of O 2 , CO 2 , and N 2 was used to calibrate the system before each experiment.
Animals were acclimated to the chambers over the first 24 hours and data was collected over the subsequent 48 hours. Mice were analyzed in two sets (eight mice per set, four per virus injected) in individual calorimeter chambers maintained at constant temperature and humidity. The mice had free access to water and powdered food presented from a food hopper attached to a scale. The volume of water intake and the weight of food consumed was recorded electronically. Room air gas was infused into each chamber at a set rate and every 15 minutes, both O 2 and CO 2 concentrations were measured in each chamber. The rate of oxygen consumption (VO 2 ) and carbon dioxide production (VCO 2 ) were calculated and averaged over the entire period as well as for the light and dark cycle for each mouse. In order to compare animals of different sizes, the consumption (VO 2 ) and production (VCO 2 ) values are normalized with respect to body weight and corrected according to a metabolically effective mass value (0.75) using the following equations:
